Aurobindo Pharma & Covaxx to develop corona vaccine for India, Unicef
New Delhi: Aurobindo Pharma Limited and Covaxx, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India…